drugset

drugset / Trial / NCT01383954

The Efficacy of Diclofenac Gel for Breakthrough Pain and the Neuropathic Components of Pain in Knee Osteoarthritis

NCT01383954 ↗

Phase 4 Completed 52 enrolled Brigham and Women's Hospital Endo USA Inc., a Keenova Therapeutics Company · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this proposed study is to conduct a trial with knee osteoarthritis (OA) patients using the diclofenac gel.

Timeline

Start: 2011-06
Primary completion: 2012-08
Completion: 2012-12

Publications

Edwards RR, Dolman AJ, Martel MO, Finan PH, Lazaridou A, Cornelius M, Wasan AD. Variability in conditioned pain modulation predicts response to NSAID treatment in patients with knee osteoarthritis. BMC Musculoskelet Disord. 2016 Jul 13;17:284. doi: 10.1186/s12891-016-1124-6.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Diclofenac	Other / unclassified	4 g	Topical

Indications